1Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126.

2Lusis AJ (2000) Atherosclerosis. Nature 407: 233-241.

3Glass CK, Witztum JL (2001) Atherosclerosis: the road ahead. Cell 104: 503-516.

4Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30: 1282-1292.

5Van der Wal AC, Becker AE (1999) Atherosclerotic plaque rupture: pathologic basis of plaque stability and instability. Cardiovasc Res 41: 334-344.

6Cortez D, Pham S, Jin y-F, Toba H, Lindsay ML, et al.( 2013) The elusive plaque: translational biologypPotential. J Cardio Vasc Med 1: 1-3.

7Conover CA (2012) Key questions and answers about pregnancy-associated plasma protein-A. Trends Endocrinol Metab 23: 242-249.

8Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, et al. (2001) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345: 1022-1029.

9Schulz O, Reinicke M, Kramer J, Berghofer G, Bensch R, et al. (2011) Pregnancy-associated plasma protein A values in patients with stable cardiovascular disease: use of a new monoclonal antibody-based assay. Clin Chim Acta 412: 880-886.

10Meir KS, Leitersdorf E (2004) Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24: 1006-1014.

11Harrington SC, Simari RD, Conover CA (2007) Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 100: 1696-1702.

12Conover CA, Mason MA, Bale LK, Harrington SC, Nyegaard M, et al. (2010) Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Am J Physiol Heart Circ Physiol 299: H284-H291.

13Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, et al. (2004) A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res 95: 981-988.

14Kullo IJ, Edwards WD, Schwartz RS (1998) Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med 129: 1050-1060.

15Mader JR, Resch ZT, McLean GR, Mikkelsen JH, Oxvig C, et al. (2013) Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy. J Endocrinol 219: 51-58.

16Jackson CL, Bennett MR, Biessen AL, Johnson JL, Krams R (2007) Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol 27: 714-720.

17Williams H, Johnson JL, Carson KGS, Jackson CL (2002) Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 22: 788-792.

18Johnson J, Carson K, Williams H, Karanam S, Newby A, et al. (2005) Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 111: 1422-1430.

19Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, et al. (2006) Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 26: 851-856.

20Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, et al. (2001) Healed plaque ruptures and sudden coronary death evidence that subclinical rupture has a role in plaque progression. Circulation 103: 934-940.

21Schwartz SM, Galis ZS, Rosenfeld ME, Falk E (2007) Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 27: 705-713.

22Bennett MR (2002) Breaking the plaque: evidence for plaque rupture in animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 22: 713-714.

23Johnson JL, Jackson CL (2001) Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154: 399-406.

24Lutgens E, van Suylen R-J, Faber GC, Gijbels MJ, Eurlings PM, et al. (2003) Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol 23: 2123-2130.

25Rosenfeld ME, Polinski P, Virmani R, Kauser K, Rubanyi G, et al. (2000) Advanced atherosclerotic lesions in the innominate artery of the apoE knockout mouse. Arterioscler Thromb Vasc Biol 20: 2587-2592.

26Gough PJ, Gomez IG, Wille PT, Raines EW (2006) Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116:59-69.

27Conover CA, Bale LK, Harrington SC, Resch ZT, Overgaard MT, et al. (2006) Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am J Physiol Cell Physiol 290: C183-C188.

28Conover CA, Harrington SC, Bale LK (2008) Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Growth Horm IGF Res 18: 213-220.

29Shai S-Y, Sukhanov S, Higashi Y, Vaughn C, Kelly J, et al. (2010) Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stabolity. Arterioscler Thromb Vasc Biol 30: 1916-1924.

30Zhao X-Y, Wang X-F, Li L, Zhang J-Y, Du Y-Y, (2013) Plaque characteristics and serum pregnancy-associated plasma protein A levels predict the no-reflow phenomenon after percutaneous coronary intervention. J Intl Med Res 41: 30-316.